Experiment 442395
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | WINICK,NJ: MC KENNA,RW: SHUSTER,JJ: SCHNEIDER,NR: BOROWITZ,MJ: BOWMAN,WP: JACARUSO,D: KAMEN,BA: BUCHANAN,GR:. (1993). SECONDARY ACUTE MYELOID LEUKEMIA IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH ETOPOSIDE.. 11(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | OF 205 CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH COMPOUND, 10 DEVELOPED ACUTE MYELOID LUEKEMIA (AML) 23-68 MO. FOLLOWING DIAGNOISIS. RISK OF SECONDARY AML AT 4 YEARS IS 5.9%. CUMULATIVE DOSE GIVEN AS PER DALLASI. |
| Dose amount | 9.9 GM |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |